![](/img/cover-not-exists.png)
Randomized phase II trial of Abiraterone alone or with Dasatinib in men with metastatic castration-resistant prostate cancer (mCRPC)
Dorff, Tanya B., Quinn, David I., Pinski, Jacek K., Goldkorn, Amir, Sadeghi, Sarmad, Tsao-Wei, Denice, Groshen, Susan, Kuhn, Peter, Gross, Mitchell E.Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2019.02.010
Date:
March, 2019
File:
PDF, 760 KB
english, 2019